Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SpainBack to Spain

Clinical trials in Elche – page 2

136 clinical trials in Elche, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Elche at a glance
136
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

136 trials in Elche

Open in trial search

Bladder cancer

Recruiting

Study of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Astellas Pharma Global Development Inc.

Oesophageal adenocarcinoma

Recruiting

Study of denikitug alone or with drug combination in adults with HER2‑negative metastatic gastric, gastroesophageal junction and esophageal adenocarcinoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Gilead Sciences Inc.

Diverticulitis

Recruiting

Outpatient Treatment Without Antibiotics or with Ciprofloxacin, Cefuroxime, Cefditoren Pivoxil, Amoxicillin/Clavulanic Acid, and Metronidazole in Adults with Acute Uncomplicated Diverticulitis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Conjunctivitis allergic+1

Recruiting

Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.

Conjunctivitis allergic+1

Recruiting

Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.

Squamous cell carcinoma of lung+4

Recruiting

A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.

Colorectal cancer metastatic

Recruiting

A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

HIV infection

Recruiting

A study of islatravir and ulonivirine for adults with HIV who have not received previous treatment

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Merck Sharp & Dohme LLC

Parkinson's disease

Recruiting

A study comparing prasinezumab with placebo for people with early-stage Parkinson's disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG

Mite allergy

Recruiting

A study testing dust mite allergy extracts from Dermatophagoides pteronyssinus and Dermatophagoides farinae for patients with allergic rhinoconjunctivitis with or without controlled asthma

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:LETI Pharma S.L.U.

Parkinson's disease

Recruiting

A Study Testing the Safety of IRL757 in Adults with Parkinson's Disease Who Have Apathy

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Integrative Research Laboratories Sweden AB

Glomerulonephritis membranous

Recruiting

A Study of Povetacicept Compared to Tacrolimus for Adults with Primary Membranous Nephropathy

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Povetacicept
  • Sponsor:Vertex Pharmaceuticals Inc.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Elche

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on advanced cancer treatments, including studies for bladder, breast, gastric, and pancreatic cancers. Research encompasses novel combination therapies and targeted treatments.

  • Breast Cancer Therapies
  • Bladder Cancer Treatments
  • Gastric Cancer Studies
  • Pancreatic Cancer Research

Multiple trials evaluating immunotherapy combinations and targeted molecular approaches for various cancer types.

02 Infectious Diseases

Critical research in viral and bacterial infections, with significant focus on HIV treatment optimization and COVID-19 therapeutic interventions.

  • HIV Treatment Studies
  • COVID-19 Therapeutics
  • Septic Shock Management

Emphasis on developing innovative treatment approaches and improving patient outcomes in infectious diseases.

03 Neurological Disorders

Advanced research into neurodegenerative conditions, focusing on innovative treatments for Huntington's Disease and Multiple System Atrophy.

  • Huntington's Disease Therapeutics
  • Multiple System Atrophy Studies
  • Parkinson's Disease Research

Trials evaluating novel therapeutic approaches to address neurological disease progression and symptoms.

Back to SpainAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.